MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
© 1991 Nature Publishing Group
Suggest Documents
Oligonucleotide labeling methods. 3. Direct labeling of oligonucleotides employing a novel, non-nucleosidic, 2-aminobutyl-1,3-propanediol backbone.
Backbone conformational change in the A to B Transition of deoxyribonucleic acid.
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs.
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs.
Need for change in patents for drugs.
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.
An invertebrate with a backbone.
NMR studies of an oligonucleotide with an unusual structure induced by platinum anti-cancer drugs.
Talking about friends, drugs, and change: meanings of friendship in substance abusers' change talk.
PESI - a taxonomic backbone for Europe.
Nitrogen Backbone Oligomers.
Oligonucleotide therapy.
Behaviour change interventions to promote prescribing of generic drugs: a rapid evidence synthesis and systematic review.
Poly(oligonucleotide).
Oligonucleotide therapeutics.
Ankylosing spondylitis: A state of the art factual backbone.
Regenerative medicine: Rebuilding the backbone.
emtricitabine in treatment naïve and experienced HIV-positive patients.
Managing service change in post HIV drugs services--a case study from Inner London.
Triazine-Based Sequence-Defined Polymers with Side-Chain Diversity and Backbone-Backbone Interaction Motifs.
Structural dependence of oligonucleotide photooxidation.
Oligonucleotide therapeutics in cancer.
L. monocytogenes oligonucleotide probe.
Sofosbuvir as backbone of interferon free treatments.
Oligonucleotide drugs. A change of backbone.
© 1991 Nature Publishing Group...
142KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Oligonucleotide labeling methods. 3. Direct labeling of oligonucleotides employing a novel, non-nucleosidic, 2-aminobutyl-1,3-propanediol backbone.
Backbone conformational change in the A to B Transition of deoxyribonucleic acid.
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs.
Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs.
Need for change in patents for drugs.
Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.
An invertebrate with a backbone.
NMR studies of an oligonucleotide with an unusual structure induced by platinum anti-cancer drugs.
Talking about friends, drugs, and change: meanings of friendship in substance abusers' change talk.
PESI - a taxonomic backbone for Europe.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms